68 results on '"Minna, John D."'
Search Results
2. Snail acetylation by autophagy‐derived acetyl‐coenzyme A promotes invasion and metastasis of KRAS ‐ LKB1 co‐mutated lung cancer cells
3. Cover Image, Volume 121, Number 8‐9, August 2020
4. Ubiquitin C‐terminal hydrolase‐L1 has prognostic relevance and is a therapeutic target for high‐grade neuroendocrine lung cancers
5. From clinical specimens to human cancer preclinical models—a journey the NCI‐cell line database—25 years later
6. eIF2 β, a subunit of translation-initiation factor EIF2, is a potential therapeutic target for non-small cell lung cancer
7. Identification of proteasomal catalytic subunit PSMA6 as a therapeutic target for lung cancer
8. On comparing heterogeneity across biomarkers
9. Clinicopathologic features and outcomes of patients with lung adenocarcinomas harboringBRAFmutations in the Lung Cancer Mutation Consortium
10. TIMELESS is overexpressed in lung cancer and its expression correlates with poor patient survival
11. The circadian clock geneBMAL1is a novel therapeutic target for malignant pleural mesothelioma
12. Oncogenic KRAS-induced interleukin-8 overexpression promotes cell growth and migration and contributes to aggressive phenotypes of non-small cell lung cancer
13. Pivotal role of epithelial cell adhesion molecule in the survival of lung cancer cells
14. Alternative splicing of Caspase 9 is modulated by the PI3K/Akt pathway via phosphorylation of SRp30a
15. Sporadic breast cancer patients' germline DNA exhibit an AT-rich microsatellite signature
16. A catalog of genes homozygously deleted in human lung cancer and the candidacy ofPTPRDas a tumor suppressor gene
17. METgene amplification orEGFRmutation activate MET in lung cancers untreated with EGFR tyrosine kinase inhibitors
18. Immortalization of human small airway epithelial cells with characteristics of bronchioalveolar stem cells
19. Homozygous deletion scanning of the lung cancer genome at a 100‐kb resolution
20. RhoB is frequently downregulated in non‐small‐cell lung cancer and resides in the 2p24 homozygous deletion region of a lung cancer cell line
21. Exclusive mutation in epidermal growth factor receptor gene, HER‐2, and KRAS, and synchronous methylation of nonsmall cell lung cancer
22. Abnormal methylation of the common PARK2 and PACRG promoter is associated with downregulation of gene expression in acute lymphoblastic leukemia and chronic myeloid leukemia
23. High resolution analysis of non-small cell lung cancer cell lines by whole genome tiling path array CGH
24. Genetic and epigenetic inactivation ofLTFgene at 3p21.3 in lung cancers
25. Gain of a region on 7p22.3, containing MAD1L1, is the most frequent event in small‐cell lung cancer cell lines
26. Identification of chromosome arm 9p as the most frequent target of homozygous deletions in lung cancer
27. Dose effect of smoking on aberrant methylation in non-small cell lung cancers
28. Loss of heterozygosity of chromosome 12p does not correlate withKRAS mutation in non-small cell lung cancer
29. Aberrant methylation of the cyclin D2 promoter in primary small cell, nonsmall cell lung and breast cancers
30. Aberrant methylation of multiple genes in the upper aerodigestive tract epithelium of heavy smokers
31. Aberrant methylation ofTMS1 in small cell, non small cell lung cancer and breast cancer
32. Smoke exposure, histologic type and geography-related differences in the methylation profiles of non-small cell lung cancer
33. A case-control analysis of lymphocytic chromosome 9 aberrations in lung cancer
34. Infrequent Mutation of thehBUB1andhBUBR1Genes in Human Lung Cancer
35. Two regions of homozygous deletion clusters at chromosome band 9p21 in human lung cancer
36. Two identical triplet sisters carrying a germlineBRCA1 gene mutation acquire very similar breast cancer somatic mutations at multiple other sites throughout the genome
37. Refined mapping of two regions of loss of heterozygosity on chromosome band 11q23 in lung cancer
38. Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer
39. Allelotyping demonstrates common and distinct patterns of chromosomal loss in human lung cancer types
40. Precise localization of theFHIT gene to the common fragile site at 3p14.2 (FRA3B) and characterization of homozygous deletions within FRA3B that affectFHIT transcription in tumor cell lines
41. NCI series of cell lines: An historical perspective
42. NCI-navy medical oncology branch cell line data base
43. Correlation of in vitro drug sensitivity testing results with response to chemotherapy and survival: Comparison of non-small cell lung cancer and small cell lung cancer
44. Molecular mapping of deletion sites in the short arm of chromosome 3 in human lung cancer
45. Erythroleukemia and other hematologic complications of intensive therapy in long-term survivors of small cell lung cancer
46. Delayed hypersensitivity skin testing as a prognostic indicator in patients with small cell lung cancer
47. Abdominal computed tomography in small cell lung cancer: Assessment of extent of disease and response to therapy
48. CNS metastases in small cell bronchogenic carcinoma.Increasing frequency and changing pattern with lengthening survival
49. Clinical implications of cytogenetic studies in cutaneous t-cell lymphoma (CTCL)
50. The hematopoietic toxicity of regional radiation therapy. Correlations for combined modality therapy with systemic chemotherapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.